Novonesis A/s Class B · OMXCOP:NSIS_B

Novonesis A/s Class B — Novozymes — H1 2014 Earnings Presentation

8 slides from Novonesis A/s Class B's earnings presentation, Aug 14, 2014

  1. Slide 1: Conference Call 1H 2014

    CONFERENCE CALL 1H 2014 August 14, 2014

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement This presentation and its related comments contain forward- looking statements, including financial expectations. Forward-looking statements are by their very nature associated with risks and uncertainties that may cause actual results to differ materially from expectations. Th

  3. Slide 3: 1H 2014 Summary

    1H 2014 Summary Satisfactory sales growth Sales and organic growth • 8% organic sales growth driven by Household Care 1H 2012 - 1H 2014 DKKm and Bioenergy 12% 6,200 • 4 %-points negative impact from currencies 10% 6,094 • Sales growth slowed down during the period as 8% 5,870 5,800 expected followin

  4. Slide 4: Sales & Markets

    Sales & Markets  1H 2014 sales: DKK +4%, LCY +8%, organic +8% Sales by industry, DKKm 1H 2014 1H 2013  Q2 2014 sales: DKK +1%, LCY +5%, organic +5% • Household Care: Emerging markets doing well despite weakness in China. Consumer down-trading Household 2,124 +2%/+5% in developed markets hampered g

  5. Slide 5: Business Operations in Detail

    Business Operations in Detail Household Care; growth fluctuates Bioenergy; power of innovation Quarterly organic growth rates, 2008-2014 Sales performance & US production, 2012-2014 30% 140 Spirizyme® Achieve & Olexa® launched 130 20% 120 Avantec® launched 10% 110 100 0% 90 -10% 80 Q1'08 Q2'08 Q3'08

  6. Slide 6: R&D Activity Update: Bioenergy Strategy Overview

    R&D Activity Update: Bioenergy Strategy Overview Grain Ethanol (1G) Biomass Conversion (2G) New Opportunities - Drive more yield - Enable commercialization - Explore biodiesel and sugar cane 3.00 gal/bu Total production cost development 2013 Global biofuels production, ~30 bn gallons* Ethanol yield

  7. Slide 7: 1H 2014 Financial Performance

    1H 2014 Financial Performance Strong financial performance in 1H’14 2014 2014 Realized Outlook Outlook • Continued productivity improvements and favorable Key financials 1H 2014 August 14 Apr. 24 product mix more than off-set negative impact on gross margin from The BioAg Alliance and currencies Sal

  8. Slide 8: Novozymes - Rethink Tomorrow

    novozymes’ Rethink Tomorrow

Novozymes — H1 2014 Earnings Presentation on 6ix